Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enstilar Foam in Nail Psoriasis
NCT04227288Phase 4Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Nov 2021
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of calcipotriol + betamethasone in nail psoriasis, sponsored by University of Alabama at Birmingham. Primary endpoint: Clinical Improvement in Nail Thickness of Target Nail at 24 weeks. Started Nov 2021; status: completed.
02
Drugs
calcipotriol + betamethasone
03
Conditions
nail psoriasis
Beyond the preview
Go deeper on NCT04227288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04227288.